Ohno M - Search Results

1

Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.

Ohno M, Yamaguchi I, Yamamoto I, Fukuda T, Yokota S, Maekura R, Ito M, Yamamoto Y, Ogura T, Maeda K, Komuta K, Igarashi T, Azuma J. Ohno M, et al. Int J Tuberc Lung Dis. 2000 Mar;4(3):256-61. Int J Tuberc Lung Dis. 2000. PMID: 10751073

2

CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin.

Zhou Q, Yamamoto I, Fukuda T, Ohno M, Sumida A, Azuma J. Zhou Q, et al. Among authors: ohno m. Eur J Clin Pharmacol. 1999 Mar;55(1):43-7. doi: 10.1007/s002280050590. Eur J Clin Pharmacol. 1999. PMID: 10206083

3

Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.

Ohno M, Yamaguchi I, Ito T, Saiki K, Yamamoto I, Azuma J. Ohno M, et al. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):861-5. doi: 10.1007/s002280050708. Eur J Clin Pharmacol. 2000. PMID: 10805065

4

Specific determination of urinary 6beta-hydroxycortisol and cortisol by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.

Ohno M, Yamaguchi I, Saiki K, Yamamoto I, Azuma J. Ohno M, et al. J Chromatogr B Biomed Sci Appl. 2000 Sep 1;746(1):95-101. doi: 10.1016/s0378-4347(00)00122-5. J Chromatogr B Biomed Sci Appl. 2000. PMID: 11048745

5

Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers.

Fukuda T, Yamamoto I, Nishida Y, Zhou Q, Ohno M, Takada K, Azuma J. Fukuda T, et al. Among authors: ohno m. Br J Clin Pharmacol. 1999 Apr;47(4):450-3. doi: 10.1046/j.1365-2125.1999.00913.x. Br J Clin Pharmacol. 1999. PMID: 10233212 Free PMC article.

6

CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers.

Fukuda T, Onishi S, Fukuen S, Ikenaga Y, Ohno M, Hoshino K, Matsumoto K, Maihara A, Momiyama K, Ito T, Fujio Y, Azuma J. Fukuda T, et al. Among authors: ohno m. Pharmacogenomics J. 2004;4(1):34-9. doi: 10.1038/sj.tpj.6500218. Pharmacogenomics J. 2004. PMID: 14647405

7

Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent.

Hirasawa Y, Sugimoto T, Fukuyama S, Kato Y, Takamatu H, Ohno M, Nishino S, Kato M, Maeda K, Seki J, Kita Y. Hirasawa Y, et al. Among authors: ohno m. Eur J Pharmacol. 1996 May 6;303(1-2):55-9. doi: 10.1016/0014-2999(96)00105-7. Eur J Pharmacol. 1996. PMID: 8804911

8

Structure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives.

Fukuyama S, Hirasawa Y, Kato Y, Nishio M, Ohno M, Nishino S, Maeda K, Kato M, Kita Y. Fukuyama S, et al. Among authors: ohno m. J Pharmacol Exp Ther. 1997 Jul;282(1):236-42. J Pharmacol Exp Ther. 1997. PMID: 9223559

9

Cholinergic and glutamatergic activation reverses working memory failure by hippocampal histamine H1 receptor blockade in rats.

Nakazato E, Yamamoto T, Ohno M, Watanabe S. Nakazato E, et al. Among authors: ohno m. Life Sci. 2000;67(10):1139-47. doi: 10.1016/s0024-3205(00)00713-x. Life Sci. 2000. PMID: 10954048

10

FR144420, a novel, slow, nitric oxide-releasing agent.

Kita Y, Ohkubo K, Hirasawa Y, Katayama Y, Ohno M, Nishino S, Kato M, Yoshida K. Kita Y, et al. Among authors: ohno m. Eur J Pharmacol. 1995 Mar 6;275(2):125-30. doi: 10.1016/0014-2999(94)00750-2. Eur J Pharmacol. 1995. PMID: 7796846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,679 results

Search Page

Filters